Genemod, which has raised $6.2 million in funding, is backed by investors including Dolby Family Ventures LLC, Futureland Ventures LLC, Defy.vc LP, Vulcan Capital LLC, LDV Partners LLP, Canaan Partners LLC, and Omicron Media LLC. The company aims to transform laboratory expectations into reality, enabling labs to perform at their full potential and manage large and complex datasets efficiently.
Key takeaways:
- Genemod Inc., a cloud-based workspace collaboration startup for biopharma, has launched a new artificial intelligence solution to enhance lab productivity and global collaboration.
- The AI solution uses machine learning algorithms to facilitate tasks such as streamlining documentation, managing large quantities of data, and providing secure, traceable backups accessible from any location.
- Genemod argues that the need for remote access to automated workflows and data has become a significant workplace expectation, driving the digital transformation of laboratories.
- The company has raised $6.2 million in funding from investors including Dolby Family Ventures LLC, Futureland Ventures LLC, Defy.vc LP, Vulcan Capital LLC, LDV Partners LLP, Canaan Partners LLC and Omicron Media LLC.